angiotensin ii has been researched along with naproxen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foidart, JB; Mahieu, P | 1 |
| Dunham, EW; Sakr, HM | 1 |
| Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH | 1 |
3 other study(ies) available for angiotensin ii and naproxen
| Article | Year |
|---|---|
Glomerular mesangial cell contractility in vitro is controlled by an angiotensin-prostaglandin balance.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Fluorescent Antibody Technique; Glomerular Mesangium; Indomethacin; Lipoxygenase Inhibitors; Microscopy, Phase-Contrast; Naproxen; Prostaglandins; Prostaglandins E; Pyrazoles; Rats; Receptors, Angiotensin | 1986 |
Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Fatty Acids, Essential; Indomethacin; Kidney; Male; Naproxen; Norepinephrine; Rats; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance; Vasoconstriction | 1982 |
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents | 2010 |